{"nct_id":"NCT05144945","title":"Study Describing the Immunogenicity and Safety of Quadrivalent Recombinant Influenza Vaccine (RIV4) Versus a Licensed Quadrivalent-inactivated Influenza Vaccine (IIV4) (Fluarix® Quadrivalent) in Participants 18 Years of Age and Older in South Korea","status":"COMPLETED","status_verified_date":"2025-09","start_date":"2021-12-07","start_date_type":"ACTUAL","primary_completion_date":"2022-09-01","primary_completion_date_type":"ACTUAL","completion_date":"2022-09-01","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SNY"]}